Alaunos Therapeutics, Inc. Quarterly Other Assets, Noncurrent in USD from Q3 2010 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
Alaunos Therapeutics, Inc. quarterly Other Assets, Noncurrent history and growth rate from Q3 2010 to Q4 2023.
  • Alaunos Therapeutics, Inc. Other Assets, Noncurrent for the quarter ending December 31, 2023 was $0.000, a 100% decline year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $0 -$500K -100% Dec 31, 2023 10-K 2024-04-01
Q3 2023 $0 -$500K -100% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 $500K $0 0% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $500K -$126K -20.1% Mar 31, 2023 10-Q 2023-05-10
Q4 2022 $500K -$131K -20.8% Dec 31, 2022 10-K 2024-04-01
Q3 2022 $500K +$498K +24900% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 $500K +$484K +3025% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 $626K +$441K +238% Mar 31, 2022 10-Q 2022-05-16
Q4 2021 $631K -$114K -15.3% Dec 31, 2021 10-K 2023-03-07
Q3 2021 $2K -$744K -99.7% Sep 30, 2021 10-Q 2021-11-08
Q2 2021 $16K -$728K -97.8% Jun 30, 2021 10-Q 2021-08-13
Q1 2021 $185K -$481K -72.2% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $745K +$635K +577% Dec 31, 2020 10-K 2022-03-30
Q3 2020 $746K +$637K +584% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $744K -$4.13M -84.7% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 $666K -$6.06M -90.1% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 $110K -$9.43M -98.8% Dec 31, 2019 10-K 2021-03-01
Q3 2019 $109K -$18.1M -99.4% Sep 30, 2019 10-Q 2019-11-07
Q2 2019 $4.87M -$17.1M -77.8% Jun 30, 2019 10-Q 2019-08-08
Q1 2019 $6.72M -$7.25M -51.9% Mar 31, 2019 10-Q 2019-05-08
Q4 2018 $9.54M -$3.94M -29.2% Dec 31, 2018 10-K 2020-03-02
Q3 2018 $18.2M +$17.7M +3563% Sep 30, 2018 10-Q 2018-11-09
Q2 2018 $21.9M +$21.4M +4348% Jun 30, 2018 10-Q 2018-08-08
Q1 2018 $14M +$13.5M +2740% Mar 31, 2018 10-Q 2018-05-10
Q4 2017 $13.5M +$13M +2635% Dec 31, 2017 10-K 2019-03-05
Q3 2017 $496K +$4K +0.81% Sep 30, 2017 10-Q 2017-11-06
Q2 2017 $493K $0 0% Jun 30, 2017 10-Q 2017-07-31
Q1 2017 $492K -$6K -1.21% Mar 31, 2017 10-Q 2017-05-01
Q4 2016 $493K -$1K -0.2% Dec 31, 2016 10-K 2018-03-01
Q3 2016 $492K +$1K +0.2% Sep 30, 2016 10-Q 2016-11-09
Q2 2016 $493K -$16K -3.14% Jun 30, 2016 10-Q 2016-08-09
Q1 2016 $498K +$7K +1.43% Mar 31, 2016 10-Q 2016-05-10
Q4 2015 $494K +$3K +0.61% Dec 31, 2015 10-K 2017-02-16
Q3 2015 $491K -$22K -4.29% Sep 30, 2015 10-Q 2015-11-02
Q2 2015 $509K -$4K -0.78% Jun 30, 2015 10-Q 2015-08-10
Q1 2015 $491K -$26K -5.03% Mar 31, 2015 10-Q 2015-05-07
Q4 2014 $491K -$37K -7.01% Dec 31, 2014 10-K 2016-02-24
Q3 2014 $513K -$226K -30.6% Sep 30, 2014 10-Q 2014-10-30
Q2 2014 $513K -$219K -29.9% Jun 30, 2014 10-Q 2014-08-07
Q1 2014 $517K -$226K -30.4% Mar 31, 2014 10-Q 2014-05-08
Q4 2013 $528K -$473K -47.3% Dec 31, 2013 10-K 2015-02-26
Q3 2013 $739K -$79K -9.66% Sep 30, 2013 10-Q 2013-10-22
Q2 2013 $732K -$92K -11.2% Jun 30, 2013 10-Q 2013-08-08
Q1 2013 $743K -$51K -6.42% Mar 31, 2013 10-Q 2013-05-07
Q4 2012 $1M +$230K +29.8% Dec 31, 2012 10-K 2014-03-03
Q3 2012 $818K -$64K -7.26% Sep 30, 2012 10-Q 2012-11-08
Q2 2012 $824K -$59K -6.68% Jun 30, 2012 10-Q/A 2012-08-28
Q1 2012 $794K Mar 31, 2012 10-Q 2012-05-03
Q4 2011 $771K +$407K +112% Dec 31, 2011 10-K 2013-03-18
Q3 2011 $882K +$572K +185% Sep 30, 2011 10-Q 2011-11-03
Q2 2011 $883K Jun 30, 2011 10-Q/A 2011-08-09
Q4 2010 $364K Dec 31, 2010 10-K 2012-02-29
Q3 2010 $310K Sep 30, 2010 10-Q 2011-08-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.